Newsroom | 2500 results

PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus) a biotechnology company engineering gene therapies at scale, today announced that P. Peter Ghoroghchian, M.D., Ph.D., Chief Executive Officer of Latus Bio, will participate in a fireside chat at Chardan’s 10th Annual Healthcare Conference, taking place on October 20, 2026 in New York City at 2:45 p.m. ET. Registered investors attending the conference will have the opportunity to meet directly with members of the management team thr...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal of Medicine (NEJM), providing rigorous evidence of the significant benefits of continuous glucose monitoring (CGM) for adults with Type 2 diabetes not on insulin. CONNECT participants using Dexcom G7 experienced an average 1.6% A1C reduction from a mean baseline of 8.8%,...

MELVILLE, N.Y.--(BUSINESS WIRE)--IDN will showcase its advanced identity verification integration with DESKO at Money20/20 Las Vegas, taking place October 18-21, 2026....

HANOVER, N.H.--(BUSINESS WIRE)--Argus Cognitive, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared Neurora (510(k) K260064), a tool that gives clinicians objective behavioral measures to support the diagnosis of autism in children ages 18 months through 12 years.Autism now affects 1 in 31 children in the United States, according to the Centers for Disease Control and Prevention (CDC). Yet the median age of diagnosis is nearly 4, and only about half of autistic chi...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026...

BELFAST, Ireland--(BUSINESS WIRE)--B-Secur launches ETS — a reference-based ECG test system giving wearable manufacturers an objective signal quality benchmark from bench to production....

BURLINGTON, Mass.--(BUSINESS WIRE)--PetPace, the leader in AI-powered wearable pet health technology, today announced that its award-winning PetPace Smart Health Monitoring Collar is now available at Chewy, a trusted destination for pet parents and partners, everywhere. PetPace’s groundbreaking technology gives dog and cat owners unprecedented access to continuous health monitoring and actionable insights designed to help them recognize changes in their pets’ health sooner. Unlike traditional a...

BOSTON--(BUSINESS WIRE)--Beaconcure, a clinical biometrics technology company, today announced the commercial launch of Verify Intelligence, the independent AI review module of its Verify platform. Every regulatory submission depends on hundreds or thousands of tables, listings, and figures (TLFs). Most sponsors and CROs check these outputs with double programming plus manual review. Both methods rely on people working from the same specification, so they tend to share the same blind spots. Whe...

MINNEAPOLIS--(BUSINESS WIRE)--Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that patients with essential tremor (ET) who used the Felix NeuroAI™ Wristband saw clinically meaningful and sustained functional improvement over a full year, with greater improvement the longer they used it, according to new peer-reviewed data published in Movement Disorder Clinical Practice.1 Another recent arti...

فيينا--(BUSINESS WIRE)--تعتزم علامات Neutrogena®، وAveeno®، وRegaine®*عرض 12 مجموعة جديدة من البيانات العلمية خلال المؤتمر الخامس والثلاثين للأكاديمية الأوروبية للأمراض الجلدية والتناسلية (EADV)، الذي يُعقد في فيينا خلال الفترة 30 سبتمبر إلى 3 أكتوبر.يتناول هذا البيان الصحفي الوسائط المتعددة. يمكنك الاطلاع على البيان كاملاً هنا: https://www.businesswire.com/news/home/20260930650363/ar/استعراض أحدث أبحاث Neutrogena® العلمية خلال مؤتمر EADV 2026 في فيينا، النمساستعرض الملخصات المقدَّمة أدلةً علمية...